| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/28/2006 | CN1795274A Selected rna motifs to include cell death and/or apoptosis |
| 06/28/2006 | CN1795205A Spex compositions and methods of use |
| 06/28/2006 | CN1795009A Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 06/28/2006 | CN1261575C Nucleotide peculiar to 0-antigen of 039 type bacillus coli |
| 06/28/2006 | CN1261574C Nucleotide peculiar to 0-antigen of 29 type bacillus coli |
| 06/28/2006 | CN1261573C Nucleotide with O-antigen idiocrasy against Ball's and shiga's-8 and colibacillus 0143 |
| 06/28/2006 | CN1261569C Nucleotide specific for escherichia coli 0149 O-antigen |
| 06/28/2006 | CN1261455C Recombinant humanized anti-hepatitis B surface antigen (HBsAg) Fab antibody and its preparation method |
| 06/28/2006 | CN1261446C Nucleotide specific for escherichia coli 0141 O-antigen |
| 06/28/2006 | CN1261445C Nucleotide specific for escherichia coli 0156 O-antigen |
| 06/28/2006 | CN1261444C Nucleotide specific for escherichia coli 054 O-antigen |
| 06/27/2006 | US7067726 Transgenic corn which express ligninolytic enzymes for use in papermaking, waste treatment, bioremediation and pollution control |
| 06/27/2006 | US7067722 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 06/27/2006 | US7067717 Isolated gene controlling disease resistance activity in plants and use thereof |
| 06/27/2006 | US7067650 Ribozymes targeting bradeion transcripts and use thereof |
| 06/27/2006 | US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 06/27/2006 | US7067648 Regulatory sequences of the mouse villin gene—use in transgenesis |
| 06/27/2006 | US7067646 Methods and compositions for modulating tumor suppression |
| 06/27/2006 | US7067645 useful for the visualization of protein localization and trafficking in living cells and as indicators of ectopic gene expression, thereby providing means to screen and/or select a sub-population of cells or trace cell lineage development |
| 06/27/2006 | US7067644 Expression vector for use as cloning tool in genetic engineering |
| 06/27/2006 | US7067643 Nucleases and exonucleases; radiolabelling, fluorescence |
| 06/27/2006 | US7067642 expression vectors; transformed cells; useful in diagnosing and treating conditions including cancer |
| 06/27/2006 | US7067641 oligonucleotides having reduced internucleotide charge and enhanced nuclease resistance |
| 06/27/2006 | US7067627 Schizophrenia associated genes, proteins and biallelic markers |
| 06/27/2006 | US7067497 Inhibiting the division of a malignant mammalian cell and for modulating the effects of cellular aging |
| 06/27/2006 | US7067495 Subcutaneously injecting to cells of melanoma tumor, an antisense nucleic acid molecule containing a sequence that is the complement of nucleotides 15 1698 of SEQ ID NO:1 |
| 06/27/2006 | US7067326 Binding particle for use in the biosynthesis and separation of particles in sample |
| 06/27/2006 | US7067312 PN7718 nucleic acids and use thereof |
| 06/27/2006 | US7067310 Generation plasmid in prokaryotic cell; obtain cell, incubate with nucleotide sequences, transform cell, allow homologouus recombination to occur, recover recombinamt plasmid |
| 06/27/2006 | US7067302 DNA and amino acid sequence of a tyrosine ammonia lyase enzyme from the bacterium Rhodobacter sphaeroides |
| 06/27/2006 | US7067301 Comprises nucleotide sequences coding prothrombin enzyme for diagnosis, treatment and prevention of nervous system, liver, blood and cancer disorders; wound healing agents |
| 06/27/2006 | US7067300 Comprises nucleotide sequences coding 1,3-propanediol oxidoreductase (DHAT) for conversion of 3-hydroxypropionaldehyde to 1,3 propanediol |
| 06/27/2006 | US7067298 Compositions and methods of using a synthetic Dnase I |
| 06/27/2006 | US7067297 Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them |
| 06/27/2006 | US7067295 Glucose dehydrogenase |
| 06/27/2006 | US7067288 Nucleotide sequences which code for the mdhA gene |
| 06/27/2006 | US7067287 mixing a nucleic acid-containing material with an accelerator, which binds the nucleic acids to a solid phase; isolating, washing the solid phase containing bound nucleic acids with a a chaotropic substance and then washing with a solution containing alcohol and acetate, eluting the nucleic acids |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067282 Compositions and methods using the yeast YLR110C promoter |
| 06/27/2006 | US7067277 Chimeric G proteins and uses thereof |
| 06/27/2006 | US7067274 Compositions and methods for the screening pro-apoptotic compounds |
| 06/27/2006 | US7067259 Multidrug resistance proteins in Drosophila and Anopheles |
| 06/27/2006 | US7067256 Ribozyme mediated inactivation of the androgen receptor |
| 06/27/2006 | US7067255 Hereditary hemochromatosis gene |
| 06/27/2006 | US7067254 Detection of inflammatory response in mammals; obtain cells, culture, incubate with test compound, monitor cell response, compare to control, evaluate for inflammatory response |
| 06/27/2006 | US7067252 Detecting preferential gene products in sample; obtain sample, generate antibodies to gene product, obtain cell, transform with vector containing preferential gene product, incubate with antibody, detect signal from bound antibody |
| 06/27/2006 | US7067251 Methods of directly selecting cells expressing inserts of interest |
| 06/27/2006 | US7067249 with stably expressed short hairpin rnas which degrade hbv pregenomic rna and mRNA; for treatment of cancer, hormonal therapy, immunotherapy, and radiation therapy |
| 06/27/2006 | US7067131 Methods for using anti-MUC18 antibodies |
| 06/27/2006 | US7067127 Amino and nucleotide sequences; isolated, hybrid nucleic acid; purification of enzyme |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | CA2124034C Gene coding for a protein regulating aureobasidin sensitivity |
| 06/22/2006 | WO2006066158A2 Rnai modulation of mll-af4 and uses thereof |
| 06/22/2006 | WO2006065981A2 Nucleic acid molecules for optimized cab-2 expression and their use |
| 06/22/2006 | WO2006065758A2 Diagnostic assay for wiskott-aldrich syndrome and genetically related disorders |
| 06/22/2006 | WO2006065103A1 Recombiant vector containing mj1 gene and method of site-specific integration using the same |
| 06/22/2006 | WO2006064039A1 Synthesis of phosphitylated compounds using a quaternary heterocyclic activator |
| 06/22/2006 | WO2006063717A2 Polymerase-independent analysis of the sequence of polynucleotides |
| 06/22/2006 | WO2005121327A3 Biosynthetic gene cluster for the production of a complex polyketide |
| 06/22/2006 | WO2005115130A3 Transgenic ficus, method for producing same and use thereof |
| 06/22/2006 | WO2005091751A3 Novel gene associated with type 1 diabetes and methods of use |
| 06/22/2006 | WO2005084411A3 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 06/22/2006 | WO2005030925A3 Microfluidic rotary flow reactor matrix |
| 06/22/2006 | WO2005028665A3 Campylobacter polypeptides and methods of use |
| 06/22/2006 | WO2005001051A3 Compositions and methods for regulating polysaccharides of a plant cell |
| 06/22/2006 | WO2004071419A3 Methods and compositions for modulating glutamate transport activity in the nervous system |
| 06/22/2006 | US20060137043 metabolic activity is altered by transformation with a Stress-Related Protein (SRP) coding nucleic acid |
| 06/22/2006 | US20060137041 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 06/22/2006 | US20060137036 Modified plants |
| 06/22/2006 | US20060137035 Controlling |
| 06/22/2006 | US20060137033 Cytokinin-sensing histidine kinases and methods of use |
| 06/22/2006 | US20060137029 Novel G protein-coupled receptor encoding gene and diagnostic uses therefor |
| 06/22/2006 | US20060136146 Modulators of ribosomal function and identification thereof |
| 06/22/2006 | US20060135760 Process for purifying oligonucleotide synthons |
| 06/22/2006 | US20060135759 Reusable universal polymer support for repetitive oligonucleotide synthesis |
| 06/22/2006 | US20060135758 Soybean polymorphisms and methods of genotyping |
| 06/22/2006 | US20060135757 DNA sequence in plant Caragana jubata with freeze tolerance |
| 06/22/2006 | US20060135756 Mammalian cell surface antigens; related reagents |
| 06/22/2006 | US20060135751 Human N-type calcium channel isoform and uses thereof |
| 06/22/2006 | US20060135750 Novel protein and gene encoding the same |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135462 N8- and C8-linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotides hybridization |
| 06/22/2006 | US20060135459 Targeted innate immunity |
| 06/22/2006 | US20060135458 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060135388 EGVII endoglucanase and nucleic acids encoding the same |
| 06/22/2006 | US20060134780 For producing high affinity, fully human antibodies of a desired isotype in response to immunization with any virtually any desired antigen |
| 06/22/2006 | US20060134773 Device for pretreating specimen |
| 06/22/2006 | US20060134755 IL-17 homologous polypeptides and therapeutic uses thereof |
| 06/22/2006 | US20060134754 IL-21 production in prokaryotic hosts |
| 06/22/2006 | US20060134753 consisting of a peptide fragment of SARS E2 spike protein, a peptide fragment of Pseudomonas exotoxin (PE) consisting of a binding domain and a translocation domain and a restriction enzyme site linker connecting the two; for inducing antibodies against SARS |
| 06/22/2006 | US20060134752 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor |
| 06/22/2006 | US20060134751 Identification of novel MS4A gene family members expressed by hematopoietic cells |
| 06/22/2006 | US20060134749 Protease, DNA encoding the same, and method for manufacturing protease |
| 06/22/2006 | US20060134747 Transgenic fungal strain for use as bioreactor in synthesis of glucoamylase; ethanol fermentation |
| 06/22/2006 | US20060134746 Adding photoregulated amino acids to the genetic code |
| 06/22/2006 | US20060134745 stress-related fusion proteins, antigenic peptides, and anti-stress-related antibodies; nucleic acid molecule encodes polypeptide which increases bile tolerance of cell; Lactobacillus acidophilus cell with an increased ability to survive stressful conditions compared to a wild-type |
| 06/22/2006 | US20060134744 Generating soluble human leukocyte antigens in cells from genomic DNA or cDNA, for prevention of viral, bacterial and proliferative disorders; polymerase chain reaction |
| 06/22/2006 | US20060134743 Vectors and methods for enhanced cell longevity and protein expression |
| 06/22/2006 | US20060134741 Composition and methods relating to SENP1-a sentrin-specific protease |